Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-05 11:25:58 ET
Invivyd, Inc. (IVVD) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST
Company Participants
Katie Falzone - Senior Vice President of Finance
Marc Elia
Timothy Lee - Chief Commercial Officer
William Duke - CFO, Principal Accounting Officer & Principal Executive Officer
Robert Allen - Chief Scientific Officer
...
Read the full article on Seeking Alpha
For further details see:
Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript
Invivyd Inc.
NASDAQ: IVVD
IVVD Trading
2.07% G/L:
$1.725 Last:
1,441,289 Volume:
$1.70 Open:
IVVD Latest News
March 05, 2026 07:03:00 am
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
March 05, 2026 07:01:00 am
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
IVVD Stock Data
$379,990,219
86,954,817
0.02%
28
N/A
Biotechnology & Life Sciences
Healthcare
US
New Haven
